Mavenir Names Dipesh Ranjan Senior Vice President and Head of Asia-Pacific Region
Renowned telecom and cloud expert to lead go-to-market strategy and Mavenir’s growth in APAC SINGAPORE–(BUSINESS…
Renowned telecom and cloud expert to lead go-to-market strategy and Mavenir’s growth in APAC SINGAPORE–(BUSINESS…
SAN FRANSISCO, CA / ACCESSWIRE / October 10, 2021 / BitTorrent, a leader in peer-to-peer…
GOLDEN, CO / ACCESSWIRE / October 10, 2021 / Vitro Biopharma, Inc. dba Vitro Biopharma,…
PHILADELPHIA, PA / ACCESSWIRE / October 10, 2021 / Dr. Dan McClimon, DC, BCN, is…
LOS ANGELES, CA / ACCESSWIRE / October 10, 2021 / Whether we like it or…
CUPERTINO, CA / ACCESSWIRE / October 9, 2021 / Play-to-earn gaming crypto, Everest Coin is…
— Company maintains focus on advancing ADVM-022 at low doses in patients with wet AMD…
VANCOUVER, BC / ACCESSWIRE / October 9, 2021 / Blender Bites Limited (formerly, Balsam Technologies…
ATLANTA, GA / ACCESSWIRE / October 9, 2021 / Kenney Conwell is thrilled to announce…
New York, NY, Oct 9, 2021 – (ACN Newswire) – Recently, Metalist Lab has announced…
OSLO, Norway & STERLING, Va.–(BUSINESS WIRE)–#LeifErikson–Bulk Fiber Networks, a leading builder and operator of fiber…
During the course of the profile, the founder and chief executive of computer recycling firm…
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / Komo Plant Based Foods Inc. (CSE:YUM)(OTCQB:KOMOF)(FRA:9HB)…
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / St. Anthony Gold Corp. (“St. Anthony”…
Kaplan-Meier Survival: RETHYMIC Clinical Program (Efficacy Analysis Set) and Natural History Population Kaplan-Meier Survival: RETHYMIC…
NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage…
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s…
CAMBRIDGE, Mass. and NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Six Towers Completed with a value of $350,000 VANCOUVER, British Columbia, Oct. 08, 2021 (GLOBE…
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer’s disease (AD) Gantenerumab…